Connect with us

Hi, what are you looking for?

Stock

Severn Trent shares rise on strong H1 results, capex boost

Investing.com — Shares of Severn Trent  (LON:SVT) rose on Wednesday following the release of its first-half financial results for the 2024/25 fiscal year, which showcased strong revenue growth, improved profitability, and revised capital expenditure guidance. 

At 4:43 am (0943 GMT), Severn Trent was trading 3.4% higher at £2,781.

Analysts at Jefferies described the performance as a “small positive,” citing the company’s ability to deliver consistent earnings growth and investment acceleration.

The utility company reported revenues of £1.2 billion for the first half, reflecting a 4% year-on-year increase. 

Underlying profit before interest and tax surged by 17% to £298 million, driven primarily by the regulated business segment, which saw a 21% rise in profits to £295 million. 

Adjusted earnings per share climbed to 47.2p, compared to 20.5p during the same period last year.

Severn Trent also declared an interim dividend of 48.68p per share, maintaining its policy of annual increases aligned with the Consumer Prices Index including owner occupiers’ housing costs.

Net debt rose to £7.7 billion, up by about £480 million from the full-year 2023/24 figure of £7.2 billion, reflecting the company’s robust investment in infrastructure. 

Capital expenditure for the first half reached £666 million, representing a 40% year-on-year increase. 

The rise in spending was attributed to accelerated investments under the upcoming AMP8 regulatory cycle, which aims to enhance long-term resilience and performance.

Severn Trent has now revised its capex guidance for the full year, projecting spending at the top end of its £1.3 billion to £1.5 billion range. 

This marks a notable commitment to infrastructure development amid regulatory demands. 

Lower finance costs, also mentioned in the updated guidance, offer additional support to earnings stability for the year.

Jefferies analysts noted the company’s delivery on key targets, particularly its £420 million cumulative rewards under AMP7, which implies a nominal return on regulated equity (RoRE) exceeding 13%. 

This, coupled with Severn Trent’s ability to maintain stable dividends and align its spending with strategic goals, bolstered investor confidence.

“We are concerned that we see minimal movement from Ofwat and our bearish stance may be one factor that crystallises a better outcome, although there could be a CMA referral if companies feel the regulatory challenge is too tough,” said analysts at Barclays (LON:BARC) in a note.

This post appeared first on investing.com






    You May Also Like

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Editor's Pick

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    Boeing has already braced investors for a rough quarterly report. Now, new CEO Kelly Ortberg has the chance to share his vision for the troubled manufacturer, from a...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 balanceandcharge.com